Cite
HARVARD Citation
Julius, J. et al. (2013). Evaluation of Pegylated Liposomal Doxorubicin Dose on the Adverse Drug Event Profile and Outcomes in Treatment of Recurrent Endometrial Cancer. International journal of gynecological cancer. 23 (2), pp. 348-354. [Online].